ArticleLangenbeck's archives of surgery2026
Current German practices in the prevention and management of postoperative pancreatic fistula following pancreatoduodenectomy: a nationwide survey.
Article in Langenbeck's archives of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative pancreatic fistula (POPF) is the most frequent and clinically significant complication following pancreatoduodenectomy (PD) and represents the leading cause of postoperative mortality. Prevention, early recognition and adequate treatment are crucial for improving outcomes.
methodsA nationwide survey was conducted in October and November 2024, targeting 112 German hospitals routinely performing pancreatoduodenectomies. The questionnaire assessed surgical volumes, preferred anastomotic techniques, prophylactic and therapeutic strategies for POPF and postoperative monitoring practices. Data were collected via paper-based forms and QR code-assisted online formats.
resultsA total of 77 hospitals, with an average annual volume of 45 PDs, participated in the survey (69% response rate). The pancreas was most commonly anastomosed with the jejunum (88%), with duct-to-mucosa pancreatojejunostomy (PJ) being the most frequently employed technique (39%). Abdominal drainage was routinely used in 91% of centers, with significantly higher rates observed in non-university and low-volume hospitals. Most participants estimated that 20–30% of cases involved high-risk anastomoses, primarily based on pancreatic texture and duct diameter. Only 18% of hospitals reported modifying their anastomotic technique in high-risk situations. As prophylactic measures, the use of somatostatin analogs (65%) and pancreatic duct stenting (36%) were the most common strategies, while prophylactic pancreatectomy was rarely performed (≤ 5% in 83% of centers). Therapeutic management of POPF primarily involved antibiotics (57%) and somatostatin analogs (54%), with interventional drainage – preferably CT-guided (82%) – required in 0–20% of cases, according to 96% of responses. Therapeutic pancreatectomy was reported to be mainly needed in 1–5% of cases. Neither prophylactic nor therapeutic management of POPF differed significantly by hospital type or volume.
conclusionThe survey reveals substantial variability in anastomotic techniques and in prophylactic and therapeutic strategies for POPF among German surgical centers, reflecting the current lack of high-level evidence in many areas. While minimally invasive management is widely adopted, the findings underscore the need for standardized protocols, improved risk stratification and further clinical trials to strengthen evidence-based practice in pancreatic surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.